News

Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent ...
French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech-driven pharmaceutical firm Formation Bio to build AI-powered software ...
In 2024, OpenAI announced a multiyear partnership with News Corp: which is currently controlled by the Murdoch family. Through this agreement OpenAI will gain access to both current and archival ...